inflammatory Conditions, Diabetes Continue to Drive 2016 PMPY Spend
The following year, compoundedmedications ranked as the third most expensive traditional therapy class, with a PMPY spend of $46.04 (DBN ...
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Thursday, February 23, 2017
Wednesday, February 22, 2017
02/21/2017 12:17 PM EST
Organic Herbal Supply, Inc. announced today that it is conducting a voluntary nationwide recall of all lots of XtraHRD Natural Male Enhancement capsules. FDA analysis has found the product to contain Tadalafil. Tadalafil is a FDA-approved drug used as treatment for male Erectile Dysfunction (ED). The active drug ingredients are not listed on the label for this product. To date, no adverse events have been reported.
.
Second Question of the Day February 22, 2017 Current Federal Statutory Law does not address and many argue it does not permit compounding of animal drugs from bulk drug substances. The FDA, however, has previously recognized that there are limited circumstances when an animal drug compounded from bulk drug substances may be an appropriate treatment option. This recognition has been done in FDA guidance (see draft “Guidance for Industry (GFI) #230, Compounding Animal Drugs from Bulk Drug Substances.” ). With President Trump's executive order limiting regulations what does this mean for the future of animal drug compounding?
Subscribe to:
Posts (Atom)